Volitionrx (VNRX) Total Liabilities (2011 - 2025)

Volitionrx's Total Liabilities history runs 11 years deep, the most recent figure standing at $42.5 million for Q4 2025.

• Quarterly Total Liabilities rose 19.68% year-over-year to $42.5 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $42.5 million (up 19.68% YoY) and the FY2025 annual result came in at $42.5 million, up 19.68% from the prior year.
• Total Liabilities was $42.5 million for Q4 2025 at Volitionrx, roughly flat from $42.4 million in the prior quarter.
• Across five years, Total Liabilities topped out at $42.5 million in Q4 2025 and bottomed at $8.6 million in Q2 2021.
• A 5-year average of $27.3 million and a median of $22.4 million in 2023 frame the typical range for Total Liabilities.
• Annual changes were most pronounced in 2022 — Total Liabilities soared 135.28% — and 2024, when it fell 3.15%.
• Volitionrx's Total Liabilities stood at $9.8 million in 2021, then jumped by 119.3% to $21.4 million in 2022, then jumped by 71.15% to $36.7 million in 2023, then retreated by 3.15% to $35.5 million in 2024, then rose by 19.68% to $42.5 million in 2025.
• Business Quant data shows VNRX's Total Liabilities at $42.5 million in Q4 2025, $42.4 million in Q3 2025, and $41.8 million in Q2 2025.